Researchers experimenting with a protein from hepatitis B virus have developed a new technique for delivering therapeutic genes to the liver while minimizing the accidental introduction of genes to other tissues.
The ideal delivery system for a gene therapy would target only those organs or tissues that need genetic repairs.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.